3 Year Absolute Returns
76.81% ↑
NAV (₹) on 20 Aug 2026
33.75
1 Day NAV Change
0.08%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum SIP of ₹100 or ... Read more
AUM
₹ 97.66 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 62.60% |
| Hospitals & Medical Services | 29.11% |
| Chemicals - Others | 5.20% |
| Treps/Reverse Repo | 3.17% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.69% | ₹ 10.44 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 9.47% | ₹ 9.25 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.89% | ₹ 6.73 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.62% | ₹ 6.46 | Hospitals & Medical Services |
| Neuland Laboratories Ltd. | 5.57% | ₹ 5.44 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 5.20% | ₹ 5.08 | Chemicals - Others |
| Aurobindo Pharma Ltd. | 5.02% | ₹ 4.91 | Pharmaceuticals |
| Zydus Lifesciences Ltd. | 4.90% | ₹ 4.79 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 4.67% | ₹ 4.56 | Hospitals & Medical Services |
| Fortis Healthcare Ltd. | 4.16% | ₹ 4.07 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 3.60% | ₹ 3.51 | Pharmaceuticals |
| Global Health Ltd. | 3.20% | ₹ 3.13 | Hospitals & Medical Services |
| Treps | 3.17% | ₹ 3.09 | Others |
| Mankind Pharma Ltd. | 3.12% | ₹ 3.04 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 2.97% | ₹ 2.90 | Pharmaceuticals |
| Artemis Medicare Services Ltd. | 2.86% | ₹ 2.79 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 2.84% | ₹ 2.78 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 2.82% | ₹ 2.76 | Hospitals & Medical Services |
| Biocon Ltd. | 2.77% | ₹ 2.70 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 2.74% | ₹ 2.68 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 2.49% | ₹ 2.43 | Pharmaceuticals |
| Cohance Lifesciences Ltd. | 2.37% | ₹ 2.32 | Pharmaceuticals |
| Dr Agarwal's Health Care Ltd. | 1.94% | ₹ 1.89 | Hospitals & Medical Services |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 13.04% | 13.86% | 9.94% | 20.92% |
| Category returns | 4.98% | 7.41% | 6.99% | 24.15% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹30.49 | 31.40% | 174.92% | 0.00% | ₹10,709 | 1.79% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Gold ETF
ETF
Regular
|
₹140.35 | 57.18% | 162.90% | 222.22% | ₹1,370 | 0.45% |
High
|
|
LIC MF Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹42.22 | 55.20% | 157.05% | 214.03% | ₹775 | 0.35% |
High
|
|
LIC MF Gold ETF FOF
Fund of Funds
Regular
|
₹39.92 | 54.74% | 154.12% | 207.92% | ₹775 | 0.61% |
High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹64.26 | 15.18% | 103.71% | 195.98% | ₹1,145 | 1.39% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹63.09 | 15.17% | 103.54% | 194.68% | ₹1,145 | 1.39% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹63.09 | 15.17% | 103.54% | 194.68% | ₹1,145 | 1.39% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹55.39 | 13.64% | 95.88% | 178.19% | ₹1,145 | 2.73% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹55.39 | 13.64% | 95.88% | 178.18% | ₹1,145 | 2.73% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹55.39 | 13.64% | 95.88% | 178.18% | ₹1,145 | 2.73% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹37.37 | 15.36% | 83.63% | 86.75% | ₹98 | 1.42% |
Very High
|
What is the current NAV of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What is the fund size (AUM) of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What are the historical returns of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What is the risk level of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What is the minimum investment amount for LIC MF Healthcare Fund Regular IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article